Expand VNDA Menu
VNDA MENU

VNDA Stock Summary and Trading Ideas (Vanda Pharmaceuticals | NASDAQ:VNDA)

Charts for Today's Stock Price and Implied Volatility in Vanda Pharmaceuticals

13-Dec-2024

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for VNDA by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Vanda Pharmaceuticals (VNDA) Frequently Asked Questions

What does Vanda Pharmaceuticals do?

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

What symbol and exchange does Vanda Pharmaceuticals shares trade?

Vanda Pharmaceuticals trades on the NASDAQ stock market under the symbol VNDA.

What is Vanda Pharmaceuticals stock price doing today?

As of December 13, 2024, VNDA stock price declined to $4.61 with 450,616 million shares trading.

What is Vanda Pharmaceuticals's Beta?

VNDA has a beta of 0.58, meaning it tends to be less sensitive to market movements. VNDA has a correlation of 0.01 to the broad based SPY ETF.

How much is Vanda Pharmaceuticals worth?

VNDA has a market cap of $268.72 million. This is considered a Small Cap stock.

How much money does Vanda Pharmaceuticals make?

Last quarter Vanda Pharmaceuticals reported $48 million in Revenue and -$.09 earnings per share. This fell short of revenue expectation by $-1 million and exceeded earnings estimates by $.07.

What is the highest and lowest price Vanda Pharmaceuticals traded in the last 3 year period?

In the last 3 years, VNDA traded as high as $18.00 and as low as $3.30.

What are the top ETFs holding Vanda Pharmaceuticals?

The top ETF exchange traded funds that VNDA belongs to (by Net Assets): VTI, IWM, VXF, IWN, IBB.

Is Vanda Pharmaceuticals (VNDA) a good investment?

VNDA has underperformed the market in the last year with a price return of +16.4% while the SPY ETF gained +29.9%. VNDA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -9.6% and -10.5%, respectively, while the SPY returned +7.8% and +0.3%, respectively.

What are the support and resistance levels for Vanda Pharmaceuticals (VNDA)?

VNDA support price is $4.49 and resistance is $4.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VNDA shares will trade within this expected range on the day.